JPH11508548A - シアリル−ルイスｘおよびシアリル−ルイスａの模倣物としてのジグリコシル化１，２−ジオール - Google Patents

シアリル−ルイスｘおよびシアリル−ルイスａの模倣物としてのジグリコシル化１，２−ジオール

Info

Publication number
JPH11508548A
JPH11508548A JP9504171A JP50417197A JPH11508548A JP H11508548 A JPH11508548 A JP H11508548A JP 9504171 A JP9504171 A JP 9504171A JP 50417197 A JP50417197 A JP 50417197A JP H11508548 A JPH11508548 A JP H11508548A
Authority
JP
Japan
Prior art keywords
alkyl
aryl
cycloalkyl
aralkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9504171A
Other languages
English (en)
Japanese (ja)
Inventor
コルプ，ハルトムート・クリスティアン
Original Assignee
ノバルティス・アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス・アクチエンゲゼルシャフト filed Critical ノバルティス・アクチエンゲゼルシャフト
Publication of JPH11508548A publication Critical patent/JPH11508548A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
JP9504171A 1995-06-29 1996-06-26 シアリル−ルイスｘおよびシアリル−ルイスａの模倣物としてのジグリコシル化１，２−ジオール Pending JPH11508548A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1914/95 1995-06-29
CH191495 1995-06-29
PCT/EP1996/002785 WO1997001569A1 (en) 1995-06-29 1996-06-26 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a

Publications (1)

Publication Number Publication Date
JPH11508548A true JPH11508548A (ja) 1999-07-27

Family

ID=4221546

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9504171A Pending JPH11508548A (ja) 1995-06-29 1996-06-26 シアリル−ルイスｘおよびシアリル−ルイスａの模倣物としてのジグリコシル化１，２−ジオール

Country Status (19)

Country Link
EP (1) EP0836610A1 (ru)
JP (1) JPH11508548A (ru)
KR (1) KR19990028543A (ru)
CN (1) CN1196731A (ru)
AU (1) AU707474B2 (ru)
BR (1) BR9609285A (ru)
CA (1) CA2224346A1 (ru)
CZ (1) CZ419797A3 (ru)
EA (1) EA001356B1 (ru)
HU (1) HUP9801805A3 (ru)
IL (1) IL118740A0 (ru)
MX (1) MX9800218A (ru)
NO (1) NO976065L (ru)
NZ (1) NZ311686A (ru)
PL (1) PL324258A1 (ru)
SI (1) SI9620099A (ru)
SK (1) SK177897A3 (ru)
TR (1) TR199701728T1 (ru)
WO (1) WO1997001569A1 (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009507031A (ja) * 2005-09-02 2009-02-19 グリコミメティクス， インコーポレイテッド ヘテロ二官能性全セレクチン阻害剤
JP2010506832A (ja) * 2006-10-12 2010-03-04 グリコミメティクス， インコーポレイテッド ヘキソースおよびｎ−アセチルヘキソサミンの糖模倣体置換

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036587A2 (en) 2000-11-01 2002-05-10 Cor Therapeutics, Inc. Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
EP1764093A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764096A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
NZ598863A (en) * 2007-02-09 2013-11-29 Glycomimetics Inc Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
ES2655443T7 (es) 2011-12-22 2021-03-22 Glycomimetics Inc Compuestos antagonistas de E-selectina
CA2891514C (en) 2012-12-07 2020-08-25 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
CN107108679B (zh) 2014-12-03 2020-10-23 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
JP7069136B2 (ja) 2016-10-07 2022-05-17 グリコミメティクス， インコーポレイテッド 極めて強力な多量体ｅ－セレクチンアンタゴニスト
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CN111566117A (zh) 2017-12-29 2020-08-21 糖模拟物有限公司 E-选择蛋白和半乳凝素-3的异双功能抑制剂
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
CA2100412A1 (en) * 1992-07-15 1994-01-16 Yutaka Yamada Glycolipid derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009507031A (ja) * 2005-09-02 2009-02-19 グリコミメティクス， インコーポレイテッド ヘテロ二官能性全セレクチン阻害剤
JP2010506832A (ja) * 2006-10-12 2010-03-04 グリコミメティクス， インコーポレイテッド ヘキソースおよびｎ−アセチルヘキソサミンの糖模倣体置換

Also Published As

Publication number Publication date
SK177897A3 (en) 1998-08-05
NO976065D0 (no) 1997-12-23
WO1997001569A1 (en) 1997-01-16
AU707474B2 (en) 1999-07-08
AU6305396A (en) 1997-01-30
TR199701728T1 (xx) 1998-03-21
EA001356B1 (ru) 2001-02-26
BR9609285A (pt) 1999-05-11
EP0836610A1 (en) 1998-04-22
HUP9801805A3 (en) 2002-01-28
HUP9801805A2 (hu) 1998-12-28
SI9620099A (sl) 1998-08-31
CZ419797A3 (cs) 1998-06-17
NZ311686A (en) 2000-01-28
NO976065L (no) 1998-02-17
MX9800218A (es) 1998-07-31
KR19990028543A (ko) 1999-04-15
EA199800103A1 (ru) 1998-08-27
PL324258A1 (en) 1998-05-11
CA2224346A1 (en) 1997-01-16
IL118740A0 (en) 1996-10-16
CN1196731A (zh) 1998-10-21

Similar Documents

Publication Publication Date Title
JPH11508548A (ja) シアリル−ルイスｘおよびシアリル−ルイスａの模倣物としてのジグリコシル化１，２−ジオール
JP2000516224A (ja) 修飾オリゴサッカライド
US5811404A (en) Sialyl Lex analogues as inhibitors of cellular adhesion
CA2223140C (en) Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US5604207A (en) Sialyl Lex analogues as inhibitors of cellular adhesion
RU2636587C2 (ru) Способы получения гликосфинголипидов и их применение
JP4553488B2 (ja) カルボキシメチルガラクトース誘導体
DE19532902A1 (de) Neuartige Glycomimetika als Selektin-Antagonisten und daraus hergestellte entzündungshemmend wirkende Arzneimittel
JPH0899989A (ja) 新規糖脂質誘導体およびその製造用中間体
EP0373038A2 (en) New lysosphingolipid derivatives
US5243035A (en) Sialic acid-containing glycolipid derivatives
JPH09169792A (ja) セレクチンアンタゴニストとしての糖模擬体および抗炎症活性を有する医薬
JP4555466B2 (ja) 置換されたテトラヒドロピラン誘導体、それらの製造方法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JPH0699462B2 (ja) ラクト−ス高級脂肪酸誘導体
JPH02292295A (ja) エトポシドの製造方法
JP3800434B2 (ja) 擬似糖脂質
WO1999033791A1 (fr) Derives aliphatiques
DE10129888C2 (de) Verfahren zur Herstellung von perbenzylierten 1-O-Glycosiden
JPS61243074A (ja) ２，４−ジデオキシシアル酸誘導体
DE10129677C2 (de) Verfahren zur Herstellung von perbenzylierten 1-O-Glycosiden
JP2563712B2 (ja) シアル酸含有糖脂質誘導体
MXPA99001287A (en) Modified oligosaccharides
JPS637555B2 (ru)
JPH0676429B2 (ja) ラクト系列スフィンゴ糖脂質の合成法
JPH08113589A (ja) 新規タキソール誘導体